Term
|
Definition
-blood schitzonticide -weak base gets trapped in vacuoles and prevents hematin crystallization resistane due to mutated efflux transporter -prophylaxis & treatment in pregnancy -radical cure w/ primaquine -LOTS of resistance ADVERSE-can cause rash |
|
|
Term
|
Definition
-blood schitzonticide -same MOA as chloroquine -clinical cure of chloroquine resistant falciparum malaria w/ antibiotic -NOT used for prophylaxis -CYP3A4 interactions ADVERSE cinchonism, prolongation of QT, thrombocytopenia/HUS, hypoglycemia |
|
|
Term
|
Definition
-blood schitzonticide -good for resistance types -gametocidal activity-eradication -heme iron cleaves bridge forming free radicals -rapid absorption & short half life -first line MDR falciparum -replaces quinidine for sever malaria and chloroquine in pregnant -ADVERSE--neurotoxic, embryotoxicity |
|
|
Term
|
Definition
-blood schitzonticide -interferes w/ electron transport -treat/prophylaxis of chloroquine-resistant ADVERSE-rash |
|
|
Term
|
Definition
-blood schitzonticide -MOA-inhibits DHFR -use for chloroquine resistant falciparum -intermittent preventative therapy in Africa ADVERSE-high dose can cause folic acid deficiency |
|
|
Term
|
Definition
-Liver schizonticide -radical cure of vivax/ovale -terminal/primary prophylaxis -bad for G6PD deficient--greater chance of anemia -don't use in pregnant |
|
|
Term
|
Definition
-systemic antiprotozoal -prodrug converted into DNA damaging metabolite via nitrite reduction -use in trichomoniasis, giard, aembia -use w/ luminal amebicide (e.g. paramyocin or iodoquinol) |
|
|
Term
|
Definition
-luminal amebicide -binds 30S of E. hisolytica -used w/ metronidazole ADVERSE-GI distress |
|
|
Term
|
Definition
-Antihelminthic -inhibits B tubulin-No DNA replication or motility -First pass to active form -empty stomach = intestinal nematodes -fat meal = tissue parasitess -treat neurocysticerosis -ADVERSE-liver toxicity, teratogenic |
|
|
Term
|
Definition
Antihelminthic -MOA-inc. permability to Ca++ -DOA for schistosomiasis -ADVERSE-well tolerated |
|
|
Term
|
Definition
MOA-neuromuscular blockage -effective only in GI -broad spectrum |
|
|
Term
|
Definition
-MOA-paralysis via activation of glutamate-gated Cl- channels -broad spectrum -treat onchocerciasis ADVERSE-Mazzotti rxn & teratogenic |
|
|
Term
|
Definition
Antifungal -taken up by permease transporter & converted to fluorouracil by cytosine deaminase -inhibits DNA synthesis by inhibiting thymidylate synthase -Narrow spectrum-systemic candidiasis -combo w/ amphotericin B -PK-well absorbed-CNS penetraton ADVERSE-hematologic/hepatotixicity -can inhibit CYP3A4 FUNGISTATIC |
|
|
Term
|
Definition
Antifungal mitosis inhibitor MOA--disrupts mitotic spindle FUNGISTATIC -treats dermatophytic infections -was first line, NOT ANYMORE! ADVERSE-headaches, porphyria |
|
|
Term
|
Definition
FUNGICIDAL allylamine squalene epoxidase inhibitor antifungal topical use for ringworm, onchomycosis ADVERSE--skin rxns, hepatotoxic |
|
|
Term
|
Definition
14a-sterol demethylase inhibitor prevents lanosterol to ergosterol -broad spectrum -systemic & superficial mycoses ADVERSE-mild rxns, cardiac suppression, drug interactions via CYPs |
|
|
Term
|
Definition
inhibits fungal membrane stability -MOA-binds ergosterol broad spectrum ADVERSE -cytokine storm, renal toxicity, myelosuppresion |
|
|
Term
|
Definition
inhibits fungal cell wall synthesis -MOA--non-comp. inhibitor of D-glucan synthesis FUNGICIDAL use for aspergillosis and systemic candidiasis |
|
|
Term
acetazolamide/methazolamide |
|
Definition
-carbonic anhydrase inhibitor -SOA-proximal tubule -inc. delivery of NaCl to macula dense--reduces RBF and GFR -open angle glaucoma, epilepsy, altitude sickness ADVERSE--hypokalemia, renal stones, hepatic encephalopathy, reduced exretion of organic bases toxicity w/ sulfonamides |
|
|
Term
furosemid/torsemide/bumetanide |
|
Definition
Na,K,Cl symport inhibitors SOA-thick ascending limb -abolishes potential differences that drives paracellular transport of Ca++ and Mg++ -decreases uric acid excretion -reduces kidney's ability to conc. urin and dilute urine -inc. RBF & stimulates renin release -delivered by OAT1 -short half live--causes post-diuretic Na+ retention -For--hypercalcemia, hyponatremia, edema, CHF, edema of neprhotic syn. -ADVERSE-hyperuricemia, hyperglycemia, hyponatremia & hypokalemia, ototoxicity NSAIDS reduce efficacy |
|
|
Term
chlorothiazide, chlorthalidone, metolazone |
|
Definition
Na+/Cl- symport inhibitors -SOA--distal convoluted tubule -efficacy reduced w/ low GFR (unlike loops) -dec. Ca++ excretion -affects ability to dilute urine -delivered by OAT1 -for-htn, edema, diabetes insipidus, calcium nephorlithiasis & osteoporosis ADVERSE-hypokalemia, hyponatremia, hyperuricema, ED, interxns w/NSAIDS, quinidine |
|
|
Term
|
Definition
k+ sparing diuretic -SOA-late distal tubule -EnaC inhibitors abolish potential for K+ excretion -Liddle syndrome & cystic fibrosis -hyperkalemia |
|
|
Term
spironolactone/eplerenone |
|
Definition
K+ sparinge Aldosterone antagonist abolish potential for K+ excretion -primary hyperaldosteronism, hepatic cirrhosis, CHF ADVERSE-hyperkalemia Spironolactone-gynecomastia, impotence, hirsutism, dec. libido |
|
|
Term
|
Definition
osmotic diuretic SOA-loop of henle, renal tubules MOA-inc. osmolality of tubular fluid -inc. extracellular volume inc. all electrolyte excretion -inc. RBF -used for disequilibrium syndrome, CSF, intraocular pressure ADVERSE-no heart failure or cranial bleeding |
|
|
Term
|
Definition
MOA--competitive V2 receptor antagonists -inc. free water excretion w/ no effect on electrolyte or renal dynamics -used for hyponatremia w/ SIADH, ADVERSE -demeclocyline-like tetracycline -tolvaptan-GI, hyperglycemia, pyrexia |
|
|
Term
|
Definition
inhibit RAAS function MOA-inhibits ACE -vasodilation -inc. renin release, ANGI levels, decreased aldosterone, prevents bad heart stuff Uses-htn, CHF, myocardial infarction, diabetic nephropathy ADVERSE--hypotension, cough, angioedema, hyperkalemia, renal failure, fetopathic potential, rash Drug interxns--antacids, NSAIDS, K+ sparing diuretics |
|
|
Term
|
Definition
angiotensin receptor blocker -competitive inhibitor -inhibits aldosterone secretion -increases AngII, blocks AT1 receptor activation better than ACE inhibitors Uses-htn, renoprotecion in diabetes, CHF ADVERSE-teratogenic, hyperkalemia, hypotension |
|
|
Term
|
Definition
direct renin inhibitor overcomes problem of conversion of AngI to II that isn't blocked by ACE inhibitors -decreases PRA but inc. renin -no effect on bradykinin |
|
|